ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jack Copeland
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Copeland, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Copeland, J.
Related Collections
Right arrow Mechanical Circulatory Assistance

Ann Thorac Surg 2006;82:33-34
© 2006 The Society of Thoracic Surgeons

Original article: Cardiovascular

Invited commentary

Jack Copeland, MD

Department of Cardiovascular and Thoracic Surgery, University of Arizona Sarver Heart Center, 1501 N Campbell Ave, Room 4402, Tucson, AZ 85724-5071

(Email: jackcope3@aol.com).

The authors [1] have made a good case for short term (< 3 days) use of extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock. Approximately 50% of the 131 patients survived including 46 being weaned from ECMO, 14 of 28 surviving bridge to a ventricular assist device (3 weaned and 11 transplanted), and 5 being transplanted after 4 days of ECMO support. The ECMO support period gave the authors time to sort out problems of neurologic and other end-organ damage before committing to a plan for . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
 Eur J Cardiothorac SurgHome page
P. P. Caimmi, C. Molinari, F. Uberti, E. Micalizzi, G. Valente, D. A. S. G. Mary, G. Vacca, and E. Grossini
Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide
Eur J Cardiothorac Surg, April 1, 2011; 39(4): e59 - e67.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.